Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03622840 · ClinicalTrials.gov registry record · NA
Impact of Individual Cognitive Remediation for Parkinson's Disease
A NA study, sponsored by New York Institute of Technology.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03622840 is a NA study that was terminated before completion, run by New York Institute of Technology. The registered enrollment target is 12 participants.
The verdict
NCT03622840, a NA study, was terminated before completion, sponsored by New York Institute of Technology.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is an interventional clinical trial that will be conducted as a pilot project. Investigators hope to conduct the study to obtain at least 10 study completers. The plan is to screen 20 Parkinson's Disease (PD) patients attending the Academic Health Care Center (AHCC) at NYIT College of Osteopathic Medicine clinic and enroll the eligible candidates based on the inclusion and exclusion criteria. Subjects will have 11 study visits over the 11-week period. Subjects cognition will be assessed using a paper-based Test of Memory and Learning (TOMAL) tool. The same tool will be used to asses and compare the cognition at baseline, and end study visits. The weekly 30-mins of cognitive remediation exercises will be done using the Brain. HQ cognitive remediation software.
Interventions
- BEHAVIORAL Cognitive Remediation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2018-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03622840
The ClinicalTrials.gov registry entry for NCT03622840 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Remediation is the first listed.
NCT03622840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03622840 about?
NCT03622840 is a clinical study titled "Impact of Individual Cognitive Remediation for Parkinson's Disease". This is an interventional clinical trial that will be conducted as a pilot project. Investigators hope to conduct the study to obtain at least 10 study completers. The plan is to screen 20 Parkinson's Disease (PD) patients attending the Academic Health Care Center (AHCC) at NYIT College of Osteopat...
What is the current status of trial NCT03622840?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2018-07-12. Estimated completion is 2018-10-30.
What interventions are being tested in trial NCT03622840?
The interventions under investigation include: Cognitive Remediation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03622840?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.